Global Encephalitis Vaccination Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Encephalitis Vaccination market size is predicted to grow from US$ 1407 million in 2025 to US$ 1975 million in 2031; it is expected to grow at a CAGR of 5.8% from 2025 to 2031.
Encephalitis Vaccination is an effective measure for the prevention of epidemic encephalitis. It is by yellow virus arboviruses - je virus caused an acute infectious disease of the central nervous system. Often result in death or neurological sequel. Je is a zoonotic disease spread by mosquito’s classes. People and many animals may be infection source after infection Encephalitis virus.
The world's leading manufacturers of JE vaccines are Novartis, Sanofi, Chengdu Institute of Biological Products, Wuhan Institute of Biological Products, Lanzhou Institute of Biological Products, Beijing Taitan, Valneva, Bharat Biotech and Liaoning Chengda, etc.
LP Information, Inc. (LPI) ' newest research report, the “Encephalitis Vaccination Industry Forecast” looks at past sales and reviews total world Encephalitis Vaccination sales in 2024, providing a comprehensive analysis by region and market sector of projected Encephalitis Vaccination sales for 2025 through 2031. With Encephalitis Vaccination sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Encephalitis Vaccination industry.
This Insight Report provides a comprehensive analysis of the global Encephalitis Vaccination landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Encephalitis Vaccination portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Encephalitis Vaccination market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Encephalitis Vaccination and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Encephalitis Vaccination.
This report presents a comprehensive overview, market shares, and growth opportunities of Encephalitis Vaccination market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Encephalitis Vaccination market?
What factors are driving Encephalitis Vaccination market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Encephalitis Vaccination market opportunities vary by end market size?
How does Encephalitis Vaccination break out by Type, by Application?
The global Encephalitis Vaccination market size is predicted to grow from US$ 1407 million in 2025 to US$ 1975 million in 2031; it is expected to grow at a CAGR of 5.8% from 2025 to 2031.
Encephalitis Vaccination is an effective measure for the prevention of epidemic encephalitis. It is by yellow virus arboviruses - je virus caused an acute infectious disease of the central nervous system. Often result in death or neurological sequel. Je is a zoonotic disease spread by mosquito’s classes. People and many animals may be infection source after infection Encephalitis virus.
The world's leading manufacturers of JE vaccines are Novartis, Sanofi, Chengdu Institute of Biological Products, Wuhan Institute of Biological Products, Lanzhou Institute of Biological Products, Beijing Taitan, Valneva, Bharat Biotech and Liaoning Chengda, etc.
LP Information, Inc. (LPI) ' newest research report, the “Encephalitis Vaccination Industry Forecast” looks at past sales and reviews total world Encephalitis Vaccination sales in 2024, providing a comprehensive analysis by region and market sector of projected Encephalitis Vaccination sales for 2025 through 2031. With Encephalitis Vaccination sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Encephalitis Vaccination industry.
This Insight Report provides a comprehensive analysis of the global Encephalitis Vaccination landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Encephalitis Vaccination portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Encephalitis Vaccination market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Encephalitis Vaccination and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Encephalitis Vaccination.
This report presents a comprehensive overview, market shares, and growth opportunities of Encephalitis Vaccination market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Encephalitis B Vaccine
- Encephalitis Attenuated Live Vaccine
- Public Hospital
- Private Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- Sanofi
- Chengdu Institute of Biological Products
- Wuhan Institute of Biological Products
- Lanzhou Institute of Biological Products
- Beijing Taitan
- Valneva
- Bharat Biotech
- Liaoning Chengda
What is the 10-year outlook for the global Encephalitis Vaccination market?
What factors are driving Encephalitis Vaccination market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Encephalitis Vaccination market opportunities vary by end market size?
How does Encephalitis Vaccination break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Encephalitis Vaccination Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Encephalitis Vaccination by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Encephalitis Vaccination by Country/Region, 2020, 2024 & 2031
2.2 Encephalitis Vaccination Segment by Type
2.2.1 Encephalitis B Vaccine
2.2.2 Encephalitis Attenuated Live Vaccine
2.3 Encephalitis Vaccination Sales by Type
2.3.1 Global Encephalitis Vaccination Sales Market Share by Type (2020-2025)
2.3.2 Global Encephalitis Vaccination Revenue and Market Share by Type (2020-2025)
2.3.3 Global Encephalitis Vaccination Sale Price by Type (2020-2025)
2.4 Encephalitis Vaccination Segment by Application
2.4.1 Public Hospital
2.4.2 Private Hospital
2.4.3 Clinic
2.4.4 Other
2.5 Encephalitis Vaccination Sales by Application
2.5.1 Global Encephalitis Vaccination Sale Market Share by Application (2020-2025)
2.5.2 Global Encephalitis Vaccination Revenue and Market Share by Application (2020-2025)
2.5.3 Global Encephalitis Vaccination Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Encephalitis Vaccination Breakdown Data by Company
3.1.1 Global Encephalitis Vaccination Annual Sales by Company (2020-2025)
3.1.2 Global Encephalitis Vaccination Sales Market Share by Company (2020-2025)
3.2 Global Encephalitis Vaccination Annual Revenue by Company (2020-2025)
3.2.1 Global Encephalitis Vaccination Revenue by Company (2020-2025)
3.2.2 Global Encephalitis Vaccination Revenue Market Share by Company (2020-2025)
3.3 Global Encephalitis Vaccination Sale Price by Company
3.4 Key Manufacturers Encephalitis Vaccination Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Encephalitis Vaccination Product Location Distribution
3.4.2 Players Encephalitis Vaccination Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ENCEPHALITIS VACCINATION BY GEOGRAPHIC REGION
4.1 World Historic Encephalitis Vaccination Market Size by Geographic Region (2020-2025)
4.1.1 Global Encephalitis Vaccination Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Encephalitis Vaccination Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Encephalitis Vaccination Market Size by Country/Region (2020-2025)
4.2.1 Global Encephalitis Vaccination Annual Sales by Country/Region (2020-2025)
4.2.2 Global Encephalitis Vaccination Annual Revenue by Country/Region (2020-2025)
4.3 Americas Encephalitis Vaccination Sales Growth
4.4 APAC Encephalitis Vaccination Sales Growth
4.5 Europe Encephalitis Vaccination Sales Growth
4.6 Middle East & Africa Encephalitis Vaccination Sales Growth
5 AMERICAS
5.1 Americas Encephalitis Vaccination Sales by Country
5.1.1 Americas Encephalitis Vaccination Sales by Country (2020-2025)
5.1.2 Americas Encephalitis Vaccination Revenue by Country (2020-2025)
5.2 Americas Encephalitis Vaccination Sales by Type (2020-2025)
5.3 Americas Encephalitis Vaccination Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Encephalitis Vaccination Sales by Region
6.1.1 APAC Encephalitis Vaccination Sales by Region (2020-2025)
6.1.2 APAC Encephalitis Vaccination Revenue by Region (2020-2025)
6.2 APAC Encephalitis Vaccination Sales by Type (2020-2025)
6.3 APAC Encephalitis Vaccination Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Encephalitis Vaccination by Country
7.1.1 Europe Encephalitis Vaccination Sales by Country (2020-2025)
7.1.2 Europe Encephalitis Vaccination Revenue by Country (2020-2025)
7.2 Europe Encephalitis Vaccination Sales by Type (2020-2025)
7.3 Europe Encephalitis Vaccination Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Encephalitis Vaccination by Country
8.1.1 Middle East & Africa Encephalitis Vaccination Sales by Country (2020-2025)
8.1.2 Middle East & Africa Encephalitis Vaccination Revenue by Country (2020-2025)
8.2 Middle East & Africa Encephalitis Vaccination Sales by Type (2020-2025)
8.3 Middle East & Africa Encephalitis Vaccination Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Encephalitis Vaccination
10.3 Manufacturing Process Analysis of Encephalitis Vaccination
10.4 Industry Chain Structure of Encephalitis Vaccination
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Encephalitis Vaccination Distributors
11.3 Encephalitis Vaccination Customer
12 WORLD FORECAST REVIEW FOR ENCEPHALITIS VACCINATION BY GEOGRAPHIC REGION
12.1 Global Encephalitis Vaccination Market Size Forecast by Region
12.1.1 Global Encephalitis Vaccination Forecast by Region (2026-2031)
12.1.2 Global Encephalitis Vaccination Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Encephalitis Vaccination Forecast by Type (2026-2031)
12.7 Global Encephalitis Vaccination Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Encephalitis Vaccination Product Portfolios and Specifications
13.1.3 Novartis Encephalitis Vaccination Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Encephalitis Vaccination Product Portfolios and Specifications
13.2.3 Sanofi Encephalitis Vaccination Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Chengdu Institute of Biological Products
13.3.1 Chengdu Institute of Biological Products Company Information
13.3.2 Chengdu Institute of Biological Products Encephalitis Vaccination Product Portfolios and Specifications
13.3.3 Chengdu Institute of Biological Products Encephalitis Vaccination Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Chengdu Institute of Biological Products Main Business Overview
13.3.5 Chengdu Institute of Biological Products Latest Developments
13.4 Wuhan Institute of Biological Products
13.4.1 Wuhan Institute of Biological Products Company Information
13.4.2 Wuhan Institute of Biological Products Encephalitis Vaccination Product Portfolios and Specifications
13.4.3 Wuhan Institute of Biological Products Encephalitis Vaccination Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Wuhan Institute of Biological Products Main Business Overview
13.4.5 Wuhan Institute of Biological Products Latest Developments
13.5 Lanzhou Institute of Biological Products
13.5.1 Lanzhou Institute of Biological Products Company Information
13.5.2 Lanzhou Institute of Biological Products Encephalitis Vaccination Product Portfolios and Specifications
13.5.3 Lanzhou Institute of Biological Products Encephalitis Vaccination Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Lanzhou Institute of Biological Products Main Business Overview
13.5.5 Lanzhou Institute of Biological Products Latest Developments
13.6 Beijing Taitan
13.6.1 Beijing Taitan Company Information
13.6.2 Beijing Taitan Encephalitis Vaccination Product Portfolios and Specifications
13.6.3 Beijing Taitan Encephalitis Vaccination Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Beijing Taitan Main Business Overview
13.6.5 Beijing Taitan Latest Developments
13.7 Valneva
13.7.1 Valneva Company Information
13.7.2 Valneva Encephalitis Vaccination Product Portfolios and Specifications
13.7.3 Valneva Encephalitis Vaccination Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Valneva Main Business Overview
13.7.5 Valneva Latest Developments
13.8 Bharat Biotech
13.8.1 Bharat Biotech Company Information
13.8.2 Bharat Biotech Encephalitis Vaccination Product Portfolios and Specifications
13.8.3 Bharat Biotech Encephalitis Vaccination Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Bharat Biotech Main Business Overview
13.8.5 Bharat Biotech Latest Developments
13.9 Liaoning Chengda
13.9.1 Liaoning Chengda Company Information
13.9.2 Liaoning Chengda Encephalitis Vaccination Product Portfolios and Specifications
13.9.3 Liaoning Chengda Encephalitis Vaccination Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Liaoning Chengda Main Business Overview
13.9.5 Liaoning Chengda Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Encephalitis Vaccination Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Encephalitis Vaccination Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Encephalitis B Vaccine
Table 4. Major Players of Encephalitis Attenuated Live Vaccine
Table 5. Global Encephalitis Vaccination Sales byType (2020-2025) & (K Units)
Table 6. Global Encephalitis Vaccination Sales Market Share byType (2020-2025)
Table 7. Global Encephalitis Vaccination Revenue byType (2020-2025) & ($ million)
Table 8. Global Encephalitis Vaccination Revenue Market Share byType (2020-2025)
Table 9. Global Encephalitis Vaccination Sale Price byType (2020-2025) & (USD/Unit)
Table 10. Global Encephalitis Vaccination Sale by Application (2020-2025) & (K Units)
Table 11. Global Encephalitis Vaccination Sale Market Share by Application (2020-2025)
Table 12. Global Encephalitis Vaccination Revenue by Application (2020-2025) & ($ million)
Table 13. Global Encephalitis Vaccination Revenue Market Share by Application (2020-2025)
Table 14. Global Encephalitis Vaccination Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Encephalitis Vaccination Sales by Company (2020-2025) & (K Units)
Table 16. Global Encephalitis Vaccination Sales Market Share by Company (2020-2025)
Table 17. Global Encephalitis Vaccination Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Encephalitis Vaccination Revenue Market Share by Company (2020-2025)
Table 19. Global Encephalitis Vaccination Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Encephalitis Vaccination Producing Area Distribution and Sales Area
Table 21. Players Encephalitis Vaccination Products Offered
Table 22. Encephalitis Vaccination Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Encephalitis Vaccination Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Encephalitis Vaccination Sales Market Share Geographic Region (2020-2025)
Table 27. Global Encephalitis Vaccination Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Encephalitis Vaccination Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Encephalitis Vaccination Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Encephalitis Vaccination Sales Market Share by Country/Region (2020-2025)
Table 31. Global Encephalitis Vaccination Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Encephalitis Vaccination Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Encephalitis Vaccination Sales by Country (2020-2025) & (K Units)
Table 34. Americas Encephalitis Vaccination Sales Market Share by Country (2020-2025)
Table 35. Americas Encephalitis Vaccination Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Encephalitis Vaccination Sales byType (2020-2025) & (K Units)
Table 37. Americas Encephalitis Vaccination Sales by Application (2020-2025) & (K Units)
Table 38. APAC Encephalitis Vaccination Sales by Region (2020-2025) & (K Units)
Table 39. APAC Encephalitis Vaccination Sales Market Share by Region (2020-2025)
Table 40. APAC Encephalitis Vaccination Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Encephalitis Vaccination Sales byType (2020-2025) & (K Units)
Table 42. APAC Encephalitis Vaccination Sales by Application (2020-2025) & (K Units)
Table 43. Europe Encephalitis Vaccination Sales by Country (2020-2025) & (K Units)
Table 44. Europe Encephalitis Vaccination Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Encephalitis Vaccination Sales byType (2020-2025) & (K Units)
Table 46. Europe Encephalitis Vaccination Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Encephalitis Vaccination Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Encephalitis Vaccination Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Encephalitis Vaccination Sales byType (2020-2025) & (K Units)
Table 50. Middle East & Africa Encephalitis Vaccination Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Encephalitis Vaccination
Table 52. Key Market Challenges & Risks of Encephalitis Vaccination
Table 53. Key IndustryTrends of Encephalitis Vaccination
Table 54. Encephalitis Vaccination Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Encephalitis Vaccination Distributors List
Table 57. Encephalitis Vaccination Customer List
Table 58. Global Encephalitis Vaccination SalesForecast by Region (2026-2031) & (K Units)
Table 59. Global Encephalitis Vaccination RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Encephalitis Vaccination SalesForecast by Country (2026-2031) & (K Units)
Table 61. Americas Encephalitis Vaccination Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Encephalitis Vaccination SalesForecast by Region (2026-2031) & (K Units)
Table 63. APAC Encephalitis Vaccination Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Encephalitis Vaccination SalesForecast by Country (2026-2031) & (K Units)
Table 65. Europe Encephalitis Vaccination RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Encephalitis Vaccination SalesForecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Encephalitis Vaccination RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Encephalitis Vaccination SalesForecast byType (2026-2031) & (K Units)
Table 69. Global Encephalitis Vaccination RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Encephalitis Vaccination SalesForecast by Application (2026-2031) & (K Units)
Table 71. Global Encephalitis Vaccination RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Novartis Basic Information, Encephalitis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 73. Novartis Encephalitis Vaccination Product Portfolios and Specifications
Table 74. Novartis Encephalitis Vaccination Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Novartis Main Business
Table 76. Novartis Latest Developments
Table 77. Sanofi Basic Information, Encephalitis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 78. Sanofi Encephalitis Vaccination Product Portfolios and Specifications
Table 79. Sanofi Encephalitis Vaccination Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Sanofi Main Business
Table 81. Sanofi Latest Developments
Table 82. Chengdu Institute of Biological Products Basic Information, Encephalitis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 83. Chengdu Institute of Biological Products Encephalitis Vaccination Product Portfolios and Specifications
Table 84. Chengdu Institute of Biological Products Encephalitis Vaccination Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Chengdu Institute of Biological Products Main Business
Table 86. Chengdu Institute of Biological Products Latest Developments
Table 87. Wuhan Institute of Biological Products Basic Information, Encephalitis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 88. Wuhan Institute of Biological Products Encephalitis Vaccination Product Portfolios and Specifications
Table 89. Wuhan Institute of Biological Products Encephalitis Vaccination Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Wuhan Institute of Biological Products Main Business
Table 91. Wuhan Institute of Biological Products Latest Developments
Table 92. Lanzhou Institute of Biological Products Basic Information, Encephalitis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 93. Lanzhou Institute of Biological Products Encephalitis Vaccination Product Portfolios and Specifications
Table 94. Lanzhou Institute of Biological Products Encephalitis Vaccination Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Lanzhou Institute of Biological Products Main Business
Table 96. Lanzhou Institute of Biological Products Latest Developments
Table 97. BeijingTaitan Basic Information, Encephalitis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 98. BeijingTaitan Encephalitis Vaccination Product Portfolios and Specifications
Table 99. BeijingTaitan Encephalitis Vaccination Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. BeijingTaitan Main Business
Table 101. BeijingTaitan Latest Developments
Table 102. Valneva Basic Information, Encephalitis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 103. Valneva Encephalitis Vaccination Product Portfolios and Specifications
Table 104. Valneva Encephalitis Vaccination Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Valneva Main Business
Table 106. Valneva Latest Developments
Table 107. Bharat Biotech Basic Information, Encephalitis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 108. Bharat Biotech Encephalitis Vaccination Product Portfolios and Specifications
Table 109. Bharat Biotech Encephalitis Vaccination Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Bharat Biotech Main Business
Table 111. Bharat Biotech Latest Developments
Table 112. Liaoning Chengda Basic Information, Encephalitis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 113. Liaoning Chengda Encephalitis Vaccination Product Portfolios and Specifications
Table 114. Liaoning Chengda Encephalitis Vaccination Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. Liaoning Chengda Main Business
Table 116. Liaoning Chengda Latest Developments
LIST OFFIGURES
Figure 1. Picture of Encephalitis Vaccination
Figure 2. Encephalitis Vaccination Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Encephalitis Vaccination Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Encephalitis Vaccination Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Encephalitis Vaccination Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Encephalitis Vaccination Sales Market Share by Country/Region (2024)
Figure 10. Encephalitis Vaccination Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Encephalitis B Vaccine
Figure 12. Product Picture of Encephalitis Attenuated Live Vaccine
Figure 13. Global Encephalitis Vaccination Sales Market Share byType in 2025
Figure 14. Global Encephalitis Vaccination Revenue Market Share byType (2020-2025)
Figure 15. Encephalitis Vaccination Consumed in Public Hospital
Figure 16. Global Encephalitis Vaccination Market: Public Hospital (2020-2025) & (K Units)
Figure 17. Encephalitis Vaccination Consumed in Private Hospital
Figure 18. Global Encephalitis Vaccination Market: Private Hospital (2020-2025) & (K Units)
Figure 19. Encephalitis Vaccination Consumed in Clinic
Figure 20. Global Encephalitis Vaccination Market: Clinic (2020-2025) & (K Units)
Figure 21. Encephalitis Vaccination Consumed in Other
Figure 22. Global Encephalitis Vaccination Market: Other (2020-2025) & (K Units)
Figure 23. Global Encephalitis Vaccination Sale Market Share by Application (2024)
Figure 24. Global Encephalitis Vaccination Revenue Market Share by Application in 2025
Figure 25. Encephalitis Vaccination Sales by Company in 2025 (K Units)
Figure 26. Global Encephalitis Vaccination Sales Market Share by Company in 2025
Figure 27. Encephalitis Vaccination Revenue by Company in 2025 ($ millions)
Figure 28. Global Encephalitis Vaccination Revenue Market Share by Company in 2025
Figure 29. Global Encephalitis Vaccination Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Encephalitis Vaccination Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Encephalitis Vaccination Sales 2020-2025 (K Units)
Figure 32. Americas Encephalitis Vaccination Revenue 2020-2025 ($ millions)
Figure 33. APAC Encephalitis Vaccination Sales 2020-2025 (K Units)
Figure 34. APAC Encephalitis Vaccination Revenue 2020-2025 ($ millions)
Figure 35. Europe Encephalitis Vaccination Sales 2020-2025 (K Units)
Figure 36. Europe Encephalitis Vaccination Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Encephalitis Vaccination Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Encephalitis Vaccination Revenue 2020-2025 ($ millions)
Figure 39. Americas Encephalitis Vaccination Sales Market Share by Country in 2025
Figure 40. Americas Encephalitis Vaccination Revenue Market Share by Country (2020-2025)
Figure 41. Americas Encephalitis Vaccination Sales Market Share byType (2020-2025)
Figure 42. Americas Encephalitis Vaccination Sales Market Share by Application (2020-2025)
Figure 43. United States Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Encephalitis Vaccination Sales Market Share by Region in 2025
Figure 48. APAC Encephalitis Vaccination Revenue Market Share by Region (2020-2025)
Figure 49. APAC Encephalitis Vaccination Sales Market Share byType (2020-2025)
Figure 50. APAC Encephalitis Vaccination Sales Market Share by Application (2020-2025)
Figure 51. China Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 55. India Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 57. ChinaTaiwan Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Encephalitis Vaccination Sales Market Share by Country in 2025
Figure 59. Europe Encephalitis Vaccination Revenue Market Share by Country (2020-2025)
Figure 60. Europe Encephalitis Vaccination Sales Market Share byType (2020-2025)
Figure 61. Europe Encephalitis Vaccination Sales Market Share by Application (2020-2025)
Figure 62. Germany Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 63.France Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Encephalitis Vaccination Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Encephalitis Vaccination Sales Market Share byType (2020-2025)
Figure 69. Middle East & Africa Encephalitis Vaccination Sales Market Share by Application (2020-2025)
Figure 70. Egypt Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 73.Turkey Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Encephalitis Vaccination in 2025
Figure 76. Manufacturing Process Analysis of Encephalitis Vaccination
Figure 77. Industry Chain Structure of Encephalitis Vaccination
Figure 78. Channels of Distribution
Figure 79. Global Encephalitis Vaccination Sales MarketForecast by Region (2026-2031)
Figure 80. Global Encephalitis Vaccination Revenue Market ShareForecast by Region (2026-2031)
Figure 81. Global Encephalitis Vaccination Sales Market ShareForecast byType (2026-2031)
Figure 82. Global Encephalitis Vaccination Revenue Market ShareForecast byType (2026-2031)
Figure 83. Global Encephalitis Vaccination Sales Market ShareForecast by Application (2026-2031)
Figure 84. Global Encephalitis Vaccination Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Encephalitis Vaccination Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Encephalitis Vaccination by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Encephalitis Vaccination by Country/Region, 2020, 2024 & 2031
2.2 Encephalitis Vaccination Segment by Type
2.2.1 Encephalitis B Vaccine
2.2.2 Encephalitis Attenuated Live Vaccine
2.3 Encephalitis Vaccination Sales by Type
2.3.1 Global Encephalitis Vaccination Sales Market Share by Type (2020-2025)
2.3.2 Global Encephalitis Vaccination Revenue and Market Share by Type (2020-2025)
2.3.3 Global Encephalitis Vaccination Sale Price by Type (2020-2025)
2.4 Encephalitis Vaccination Segment by Application
2.4.1 Public Hospital
2.4.2 Private Hospital
2.4.3 Clinic
2.4.4 Other
2.5 Encephalitis Vaccination Sales by Application
2.5.1 Global Encephalitis Vaccination Sale Market Share by Application (2020-2025)
2.5.2 Global Encephalitis Vaccination Revenue and Market Share by Application (2020-2025)
2.5.3 Global Encephalitis Vaccination Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Encephalitis Vaccination Breakdown Data by Company
3.1.1 Global Encephalitis Vaccination Annual Sales by Company (2020-2025)
3.1.2 Global Encephalitis Vaccination Sales Market Share by Company (2020-2025)
3.2 Global Encephalitis Vaccination Annual Revenue by Company (2020-2025)
3.2.1 Global Encephalitis Vaccination Revenue by Company (2020-2025)
3.2.2 Global Encephalitis Vaccination Revenue Market Share by Company (2020-2025)
3.3 Global Encephalitis Vaccination Sale Price by Company
3.4 Key Manufacturers Encephalitis Vaccination Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Encephalitis Vaccination Product Location Distribution
3.4.2 Players Encephalitis Vaccination Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ENCEPHALITIS VACCINATION BY GEOGRAPHIC REGION
4.1 World Historic Encephalitis Vaccination Market Size by Geographic Region (2020-2025)
4.1.1 Global Encephalitis Vaccination Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Encephalitis Vaccination Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Encephalitis Vaccination Market Size by Country/Region (2020-2025)
4.2.1 Global Encephalitis Vaccination Annual Sales by Country/Region (2020-2025)
4.2.2 Global Encephalitis Vaccination Annual Revenue by Country/Region (2020-2025)
4.3 Americas Encephalitis Vaccination Sales Growth
4.4 APAC Encephalitis Vaccination Sales Growth
4.5 Europe Encephalitis Vaccination Sales Growth
4.6 Middle East & Africa Encephalitis Vaccination Sales Growth
5 AMERICAS
5.1 Americas Encephalitis Vaccination Sales by Country
5.1.1 Americas Encephalitis Vaccination Sales by Country (2020-2025)
5.1.2 Americas Encephalitis Vaccination Revenue by Country (2020-2025)
5.2 Americas Encephalitis Vaccination Sales by Type (2020-2025)
5.3 Americas Encephalitis Vaccination Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Encephalitis Vaccination Sales by Region
6.1.1 APAC Encephalitis Vaccination Sales by Region (2020-2025)
6.1.2 APAC Encephalitis Vaccination Revenue by Region (2020-2025)
6.2 APAC Encephalitis Vaccination Sales by Type (2020-2025)
6.3 APAC Encephalitis Vaccination Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Encephalitis Vaccination by Country
7.1.1 Europe Encephalitis Vaccination Sales by Country (2020-2025)
7.1.2 Europe Encephalitis Vaccination Revenue by Country (2020-2025)
7.2 Europe Encephalitis Vaccination Sales by Type (2020-2025)
7.3 Europe Encephalitis Vaccination Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Encephalitis Vaccination by Country
8.1.1 Middle East & Africa Encephalitis Vaccination Sales by Country (2020-2025)
8.1.2 Middle East & Africa Encephalitis Vaccination Revenue by Country (2020-2025)
8.2 Middle East & Africa Encephalitis Vaccination Sales by Type (2020-2025)
8.3 Middle East & Africa Encephalitis Vaccination Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Encephalitis Vaccination
10.3 Manufacturing Process Analysis of Encephalitis Vaccination
10.4 Industry Chain Structure of Encephalitis Vaccination
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Encephalitis Vaccination Distributors
11.3 Encephalitis Vaccination Customer
12 WORLD FORECAST REVIEW FOR ENCEPHALITIS VACCINATION BY GEOGRAPHIC REGION
12.1 Global Encephalitis Vaccination Market Size Forecast by Region
12.1.1 Global Encephalitis Vaccination Forecast by Region (2026-2031)
12.1.2 Global Encephalitis Vaccination Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Encephalitis Vaccination Forecast by Type (2026-2031)
12.7 Global Encephalitis Vaccination Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Encephalitis Vaccination Product Portfolios and Specifications
13.1.3 Novartis Encephalitis Vaccination Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Encephalitis Vaccination Product Portfolios and Specifications
13.2.3 Sanofi Encephalitis Vaccination Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Chengdu Institute of Biological Products
13.3.1 Chengdu Institute of Biological Products Company Information
13.3.2 Chengdu Institute of Biological Products Encephalitis Vaccination Product Portfolios and Specifications
13.3.3 Chengdu Institute of Biological Products Encephalitis Vaccination Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Chengdu Institute of Biological Products Main Business Overview
13.3.5 Chengdu Institute of Biological Products Latest Developments
13.4 Wuhan Institute of Biological Products
13.4.1 Wuhan Institute of Biological Products Company Information
13.4.2 Wuhan Institute of Biological Products Encephalitis Vaccination Product Portfolios and Specifications
13.4.3 Wuhan Institute of Biological Products Encephalitis Vaccination Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Wuhan Institute of Biological Products Main Business Overview
13.4.5 Wuhan Institute of Biological Products Latest Developments
13.5 Lanzhou Institute of Biological Products
13.5.1 Lanzhou Institute of Biological Products Company Information
13.5.2 Lanzhou Institute of Biological Products Encephalitis Vaccination Product Portfolios and Specifications
13.5.3 Lanzhou Institute of Biological Products Encephalitis Vaccination Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Lanzhou Institute of Biological Products Main Business Overview
13.5.5 Lanzhou Institute of Biological Products Latest Developments
13.6 Beijing Taitan
13.6.1 Beijing Taitan Company Information
13.6.2 Beijing Taitan Encephalitis Vaccination Product Portfolios and Specifications
13.6.3 Beijing Taitan Encephalitis Vaccination Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Beijing Taitan Main Business Overview
13.6.5 Beijing Taitan Latest Developments
13.7 Valneva
13.7.1 Valneva Company Information
13.7.2 Valneva Encephalitis Vaccination Product Portfolios and Specifications
13.7.3 Valneva Encephalitis Vaccination Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Valneva Main Business Overview
13.7.5 Valneva Latest Developments
13.8 Bharat Biotech
13.8.1 Bharat Biotech Company Information
13.8.2 Bharat Biotech Encephalitis Vaccination Product Portfolios and Specifications
13.8.3 Bharat Biotech Encephalitis Vaccination Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Bharat Biotech Main Business Overview
13.8.5 Bharat Biotech Latest Developments
13.9 Liaoning Chengda
13.9.1 Liaoning Chengda Company Information
13.9.2 Liaoning Chengda Encephalitis Vaccination Product Portfolios and Specifications
13.9.3 Liaoning Chengda Encephalitis Vaccination Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Liaoning Chengda Main Business Overview
13.9.5 Liaoning Chengda Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Encephalitis Vaccination Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Encephalitis Vaccination Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Encephalitis B Vaccine
Table 4. Major Players of Encephalitis Attenuated Live Vaccine
Table 5. Global Encephalitis Vaccination Sales byType (2020-2025) & (K Units)
Table 6. Global Encephalitis Vaccination Sales Market Share byType (2020-2025)
Table 7. Global Encephalitis Vaccination Revenue byType (2020-2025) & ($ million)
Table 8. Global Encephalitis Vaccination Revenue Market Share byType (2020-2025)
Table 9. Global Encephalitis Vaccination Sale Price byType (2020-2025) & (USD/Unit)
Table 10. Global Encephalitis Vaccination Sale by Application (2020-2025) & (K Units)
Table 11. Global Encephalitis Vaccination Sale Market Share by Application (2020-2025)
Table 12. Global Encephalitis Vaccination Revenue by Application (2020-2025) & ($ million)
Table 13. Global Encephalitis Vaccination Revenue Market Share by Application (2020-2025)
Table 14. Global Encephalitis Vaccination Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Encephalitis Vaccination Sales by Company (2020-2025) & (K Units)
Table 16. Global Encephalitis Vaccination Sales Market Share by Company (2020-2025)
Table 17. Global Encephalitis Vaccination Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Encephalitis Vaccination Revenue Market Share by Company (2020-2025)
Table 19. Global Encephalitis Vaccination Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Encephalitis Vaccination Producing Area Distribution and Sales Area
Table 21. Players Encephalitis Vaccination Products Offered
Table 22. Encephalitis Vaccination Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Encephalitis Vaccination Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Encephalitis Vaccination Sales Market Share Geographic Region (2020-2025)
Table 27. Global Encephalitis Vaccination Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Encephalitis Vaccination Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Encephalitis Vaccination Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Encephalitis Vaccination Sales Market Share by Country/Region (2020-2025)
Table 31. Global Encephalitis Vaccination Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Encephalitis Vaccination Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Encephalitis Vaccination Sales by Country (2020-2025) & (K Units)
Table 34. Americas Encephalitis Vaccination Sales Market Share by Country (2020-2025)
Table 35. Americas Encephalitis Vaccination Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Encephalitis Vaccination Sales byType (2020-2025) & (K Units)
Table 37. Americas Encephalitis Vaccination Sales by Application (2020-2025) & (K Units)
Table 38. APAC Encephalitis Vaccination Sales by Region (2020-2025) & (K Units)
Table 39. APAC Encephalitis Vaccination Sales Market Share by Region (2020-2025)
Table 40. APAC Encephalitis Vaccination Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Encephalitis Vaccination Sales byType (2020-2025) & (K Units)
Table 42. APAC Encephalitis Vaccination Sales by Application (2020-2025) & (K Units)
Table 43. Europe Encephalitis Vaccination Sales by Country (2020-2025) & (K Units)
Table 44. Europe Encephalitis Vaccination Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Encephalitis Vaccination Sales byType (2020-2025) & (K Units)
Table 46. Europe Encephalitis Vaccination Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Encephalitis Vaccination Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Encephalitis Vaccination Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Encephalitis Vaccination Sales byType (2020-2025) & (K Units)
Table 50. Middle East & Africa Encephalitis Vaccination Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Encephalitis Vaccination
Table 52. Key Market Challenges & Risks of Encephalitis Vaccination
Table 53. Key IndustryTrends of Encephalitis Vaccination
Table 54. Encephalitis Vaccination Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Encephalitis Vaccination Distributors List
Table 57. Encephalitis Vaccination Customer List
Table 58. Global Encephalitis Vaccination SalesForecast by Region (2026-2031) & (K Units)
Table 59. Global Encephalitis Vaccination RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Encephalitis Vaccination SalesForecast by Country (2026-2031) & (K Units)
Table 61. Americas Encephalitis Vaccination Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Encephalitis Vaccination SalesForecast by Region (2026-2031) & (K Units)
Table 63. APAC Encephalitis Vaccination Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Encephalitis Vaccination SalesForecast by Country (2026-2031) & (K Units)
Table 65. Europe Encephalitis Vaccination RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Encephalitis Vaccination SalesForecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Encephalitis Vaccination RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Encephalitis Vaccination SalesForecast byType (2026-2031) & (K Units)
Table 69. Global Encephalitis Vaccination RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Encephalitis Vaccination SalesForecast by Application (2026-2031) & (K Units)
Table 71. Global Encephalitis Vaccination RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Novartis Basic Information, Encephalitis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 73. Novartis Encephalitis Vaccination Product Portfolios and Specifications
Table 74. Novartis Encephalitis Vaccination Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Novartis Main Business
Table 76. Novartis Latest Developments
Table 77. Sanofi Basic Information, Encephalitis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 78. Sanofi Encephalitis Vaccination Product Portfolios and Specifications
Table 79. Sanofi Encephalitis Vaccination Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Sanofi Main Business
Table 81. Sanofi Latest Developments
Table 82. Chengdu Institute of Biological Products Basic Information, Encephalitis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 83. Chengdu Institute of Biological Products Encephalitis Vaccination Product Portfolios and Specifications
Table 84. Chengdu Institute of Biological Products Encephalitis Vaccination Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Chengdu Institute of Biological Products Main Business
Table 86. Chengdu Institute of Biological Products Latest Developments
Table 87. Wuhan Institute of Biological Products Basic Information, Encephalitis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 88. Wuhan Institute of Biological Products Encephalitis Vaccination Product Portfolios and Specifications
Table 89. Wuhan Institute of Biological Products Encephalitis Vaccination Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. Wuhan Institute of Biological Products Main Business
Table 91. Wuhan Institute of Biological Products Latest Developments
Table 92. Lanzhou Institute of Biological Products Basic Information, Encephalitis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 93. Lanzhou Institute of Biological Products Encephalitis Vaccination Product Portfolios and Specifications
Table 94. Lanzhou Institute of Biological Products Encephalitis Vaccination Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Lanzhou Institute of Biological Products Main Business
Table 96. Lanzhou Institute of Biological Products Latest Developments
Table 97. BeijingTaitan Basic Information, Encephalitis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 98. BeijingTaitan Encephalitis Vaccination Product Portfolios and Specifications
Table 99. BeijingTaitan Encephalitis Vaccination Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. BeijingTaitan Main Business
Table 101. BeijingTaitan Latest Developments
Table 102. Valneva Basic Information, Encephalitis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 103. Valneva Encephalitis Vaccination Product Portfolios and Specifications
Table 104. Valneva Encephalitis Vaccination Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Valneva Main Business
Table 106. Valneva Latest Developments
Table 107. Bharat Biotech Basic Information, Encephalitis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 108. Bharat Biotech Encephalitis Vaccination Product Portfolios and Specifications
Table 109. Bharat Biotech Encephalitis Vaccination Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Bharat Biotech Main Business
Table 111. Bharat Biotech Latest Developments
Table 112. Liaoning Chengda Basic Information, Encephalitis Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 113. Liaoning Chengda Encephalitis Vaccination Product Portfolios and Specifications
Table 114. Liaoning Chengda Encephalitis Vaccination Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. Liaoning Chengda Main Business
Table 116. Liaoning Chengda Latest Developments
LIST OFFIGURES
Figure 1. Picture of Encephalitis Vaccination
Figure 2. Encephalitis Vaccination Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Encephalitis Vaccination Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Encephalitis Vaccination Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Encephalitis Vaccination Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Encephalitis Vaccination Sales Market Share by Country/Region (2024)
Figure 10. Encephalitis Vaccination Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Encephalitis B Vaccine
Figure 12. Product Picture of Encephalitis Attenuated Live Vaccine
Figure 13. Global Encephalitis Vaccination Sales Market Share byType in 2025
Figure 14. Global Encephalitis Vaccination Revenue Market Share byType (2020-2025)
Figure 15. Encephalitis Vaccination Consumed in Public Hospital
Figure 16. Global Encephalitis Vaccination Market: Public Hospital (2020-2025) & (K Units)
Figure 17. Encephalitis Vaccination Consumed in Private Hospital
Figure 18. Global Encephalitis Vaccination Market: Private Hospital (2020-2025) & (K Units)
Figure 19. Encephalitis Vaccination Consumed in Clinic
Figure 20. Global Encephalitis Vaccination Market: Clinic (2020-2025) & (K Units)
Figure 21. Encephalitis Vaccination Consumed in Other
Figure 22. Global Encephalitis Vaccination Market: Other (2020-2025) & (K Units)
Figure 23. Global Encephalitis Vaccination Sale Market Share by Application (2024)
Figure 24. Global Encephalitis Vaccination Revenue Market Share by Application in 2025
Figure 25. Encephalitis Vaccination Sales by Company in 2025 (K Units)
Figure 26. Global Encephalitis Vaccination Sales Market Share by Company in 2025
Figure 27. Encephalitis Vaccination Revenue by Company in 2025 ($ millions)
Figure 28. Global Encephalitis Vaccination Revenue Market Share by Company in 2025
Figure 29. Global Encephalitis Vaccination Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Encephalitis Vaccination Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Encephalitis Vaccination Sales 2020-2025 (K Units)
Figure 32. Americas Encephalitis Vaccination Revenue 2020-2025 ($ millions)
Figure 33. APAC Encephalitis Vaccination Sales 2020-2025 (K Units)
Figure 34. APAC Encephalitis Vaccination Revenue 2020-2025 ($ millions)
Figure 35. Europe Encephalitis Vaccination Sales 2020-2025 (K Units)
Figure 36. Europe Encephalitis Vaccination Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Encephalitis Vaccination Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Encephalitis Vaccination Revenue 2020-2025 ($ millions)
Figure 39. Americas Encephalitis Vaccination Sales Market Share by Country in 2025
Figure 40. Americas Encephalitis Vaccination Revenue Market Share by Country (2020-2025)
Figure 41. Americas Encephalitis Vaccination Sales Market Share byType (2020-2025)
Figure 42. Americas Encephalitis Vaccination Sales Market Share by Application (2020-2025)
Figure 43. United States Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Encephalitis Vaccination Sales Market Share by Region in 2025
Figure 48. APAC Encephalitis Vaccination Revenue Market Share by Region (2020-2025)
Figure 49. APAC Encephalitis Vaccination Sales Market Share byType (2020-2025)
Figure 50. APAC Encephalitis Vaccination Sales Market Share by Application (2020-2025)
Figure 51. China Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 55. India Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 57. ChinaTaiwan Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Encephalitis Vaccination Sales Market Share by Country in 2025
Figure 59. Europe Encephalitis Vaccination Revenue Market Share by Country (2020-2025)
Figure 60. Europe Encephalitis Vaccination Sales Market Share byType (2020-2025)
Figure 61. Europe Encephalitis Vaccination Sales Market Share by Application (2020-2025)
Figure 62. Germany Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 63.France Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Encephalitis Vaccination Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Encephalitis Vaccination Sales Market Share byType (2020-2025)
Figure 69. Middle East & Africa Encephalitis Vaccination Sales Market Share by Application (2020-2025)
Figure 70. Egypt Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 73.Turkey Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Encephalitis Vaccination Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Encephalitis Vaccination in 2025
Figure 76. Manufacturing Process Analysis of Encephalitis Vaccination
Figure 77. Industry Chain Structure of Encephalitis Vaccination
Figure 78. Channels of Distribution
Figure 79. Global Encephalitis Vaccination Sales MarketForecast by Region (2026-2031)
Figure 80. Global Encephalitis Vaccination Revenue Market ShareForecast by Region (2026-2031)
Figure 81. Global Encephalitis Vaccination Sales Market ShareForecast byType (2026-2031)
Figure 82. Global Encephalitis Vaccination Revenue Market ShareForecast byType (2026-2031)
Figure 83. Global Encephalitis Vaccination Sales Market ShareForecast by Application (2026-2031)
Figure 84. Global Encephalitis Vaccination Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Packaging CDMO Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
105 pages
Global Daptomycin API Market Growth 2023-2029
US$ 3,660.00
March 2023
96 pages
Global Infectious Disease Testing Device Market Growth 2023-2029
US$ 3,660.00
February 2023
106 pages
Global Mobile Ventilator Market Growth 2024-2030
US$ 3,660.00
March 2024
114 pages
